Research Article| Volume 276, ISSUE 1-2, P66-68, January 15, 2009

Download started.


Development and validation of a predictive outcome score of cerebral venous thrombosis


      Background and purpose

      Cerebral venous thrombosis (CVT) is a rare disease with a variable outcome. The aim of this study was to develop and validate a predictive outcome score for CVT patients.


      The score was based on the 8 predictive variables of poor outcome (modified Rankin Scale score>2) from the International Study on Cerebral Vein and Dural Sinus Thrombosis: age >37, male, mental status disorder, coma, intracranial hemorrhage, deep CVT, CNS infection, and malignancy. To assign a weighted index (WI), the natural logarithm of the hazard ratio of each variable was calculated, multiplied by 10 and rounded to the nearest integer. The individual score of each patient was the sum of the WI. The validation sample consisted of a retrospective single center cohort of 90 CVT patients.


      Sixteen patients (18%) had a poor outcome. The predictive score had an area under the receiver operating characteristic curve of 0.81 (95% CI 0.71–0.90). The cut-off score with the maximum sum of sensitivity and specificity was a score14 with sensitivity of 88% (81%–95%) and specificity of 70% (61%–79%). The predictive value of a score<14 for good outcome was 96% (92%–100%), whereas the predictive value of a score14 for poor outcome was 39% (29%–49%).


      This relatively simple predictive outcome score may be useful in CVT patients. A cut-off score of 14 reliably predicts good outcome, but is less accurate in predicting poor outcome.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Stam J.
        Thrombosis of the cerebral veins and sinuses.
        N Engl J Med. 2005; 352: 1791-1798
        • Bousser M.G.
        • Ferro J.M.
        Cerebral venous thrombosis: an update.
        Lancet Neurol. 2007; 6: 162-170
        • Einhaupl K.
        • Bousser M.G.
        • de Bruijn S.F.
        • Ferro J.M.
        • Martinelli I.
        • Masuhr F.
        • Stam J.
        EFNS guideline on the treatment of cerebral venous and sinus thrombosis.
        Eur J Neurol. 2006; 13: 553-559
        • Ferro J.M.
        • Canhao P.
        • Stam J.
        • Bousser M.G.
        • Barinagarrementeria F.
        Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).
        Stroke. 2004; 35: 664-670
        • Bousser M.G.
        • Russel R.R.
        Cerebral venous thrombosis.
        in: Warlow CP Van Gijn J Major problems in neurology. WB Saunders, London, UK1997: 27-29
        • Harrell F.
        Regression coefficients and scoring rules.
        J Clin Epidemiol. 1996; 49: 819
        • Harrell F.E.
        Regression modeling strategies. Springer, New York2001
        • Connell F.A.
        • Koepsell T.D.
        Measures of gain in certainty from a diagnostic test.
        Am J Epidemiol. 1985; 121: 744-753
        • Breteau G.
        • Mounier-Vehier F.
        • Godefroy O.
        • Gauvrit J.Y.
        • Mackowiak-Cordoliani M.A.
        • Girot M.
        • Bertheloot D.
        • Hénon H.
        • Lucas C.
        • Leclerc X.
        • Fourrier F.
        • Pruvo J.P.
        • Leys D.
        Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients.
        J Neurol. 2003; 250: 29-35
        • de Bruijn S.F.
        • de Haan R.J.
        • Stam J.
        Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group.
        J Neurol Neurosurg Psychiatry. 2001; 70: 105-108
        • Dentali F.
        • Gianni M.
        • Crowther M.A.
        • Ageno W.
        Natural history of cerebral vein thrombosis: a systematic review.
        Blood. 2006; 108: 1129-1134
        • Preter M.
        • Tzourio C.
        • Ameri A.
        • Bousser M.G.
        Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients.
        Stroke. 1996; 27: 243-246
        • Stolz E.
        • Rahimi A.
        • Gerriets T.
        • Kraus J.
        • Kaps M.
        Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome.
        Clin Neurol Neurosurg. 2005; 107: 99-107
        • Terazzi E.
        • Mittino D.
        • Ruda R.
        • Cerrato P.
        • Monaco F.
        • Sciolla R.
        • Grasso E.
        • Leone M.A.
        Cerebral venous thrombosis: a retrospective multicentre study of 48 patients.
        Neurol Sci. 2005; 25: 311-315
        • Wasay M.
        • Bakshi R.
        • Bobustuc G.
        • Kojan S.
        • Sheikh Z.
        • Dai A.
        • Cheema Z.
        Cerebral venous thrombosis: analysis of a multicenter cohort from the United States.
        J Stroke Cerebrovasc Dis. 2008; 17: 49-54